Skip to content

Clinical trials

Recruiting Neoplasm Metastasis trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Status: Recruiting Country / region: Italy Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20161
20181
20191
20203
20214
20225
20236
20248
202516
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting51

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
Eli Lilly and Company5
Pfizer3
Eikon Therapeutics2
Fondazione Policlinico Universitario Agostino Gemelli IRCCS2
Gruppo Oncologico del Nord-Ovest2
IRCCS Azienda Ospedaliero-Universitaria di Bologna2
National Cancer Institute, Naples2
Nuvalent Inc.2
ALX Oncology Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis51
Breast Neoplasms10
Neoplasms7
Carcinoma, Non-Small-Cell Lung6
Colorectal Neoplasms5
Colonic Neoplasms4
Endometrial Neoplasms4
Lung Neoplasms4
Neoplasms by Site4
Pancreatic Neoplasms4

Trials

Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.